Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
about
Acute-onset rhabdomyolysis secondary to sitagliptin and atorvastatin interaction.Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers.Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.Incretin-based therapies for type 2 diabetes mellitus: current status and future prospects.Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition.Sitagliptin: a review.Pharmacokinetic evaluation of atorvastatin and sitagliptin in combination for the treatment of type 2 diabetes.Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors.Association of musculoskeletal complaints and gliptin use: review of spontaneous reports.The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels.Does Myocardial Necrosis Occur in Rhabdomyolysis?Cyclosporine A and lovastatin: the good and the bad, but who will be the winner?
P2860
Q36872923-8E3D1C21-97A8-4917-BD0F-663E72535527Q36912481-1420DB40-24AC-4A6B-B92D-972E5481895EQ37735838-3706CE44-D317-49E5-85D7-E021EF0D82B3Q37760515-BA4FCFD5-AA99-41FD-AB2F-CAD70C8B3DE1Q37872364-4EA8E912-A699-46BD-B7ED-D49E5B02DBE3Q37886184-7AEBDBAF-F3ED-4A20-BB3F-F83BCA74C324Q38010243-86E132D8-DDA4-4400-97E2-EEB0ED13A5C6Q38017726-4C9EDF65-306F-4BDF-9450-F4FAF7E18454Q38130192-9BB2D27C-A9AA-4234-9CA9-CE6F9D6A925CQ38205588-8F1D807D-D392-4941-A6D5-D53D065F8696Q39434470-AF1A2ED5-3F1B-46AD-ABC0-A80A53C32CE5Q42740015-83100186-A67F-4D1A-86F6-7CD5A3C7969AQ44294762-2D55C48D-04BC-43AC-9600-08E5DF6E7DFE
P2860
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
@en
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
@nl
type
label
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
@en
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
@nl
prefLabel
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
@en
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
@nl
P2860
P356
P1433
P1476
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
@en
P2093
Robert V DiGregorio
Yanina Pasikhova
P2860
P304
P356
10.1592/PHCO.29.3.352
P407
P577
2009-03-01T00:00:00Z